| Identification | Back Directory | [Name]
A-796260 | [CAS]
895155-26-7 | [Synonyms]
A-796260
(1-(2-Morpholinoethyl)-1H-indol-3-yl)(2,2,3,3-tetraMethylcyclopropyl)Methanone
[1-(2-morpholin-4-ylethyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone
[1-(2-Morpholin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3-tetraMethylcyclopropyl)Methanone
[1-[2-(4-Morpholinyl)ethyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
Methanone, [1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)- | [EINECS(EC#)]
806-150-0 | [Molecular Formula]
C22H30N2O2 | [MOL File]
895155-26-7.mol | [Molecular Weight]
354.49 |
| Chemical Properties | Back Directory | [Boiling point ]
492.7±35.0 °C(Predicted) | [density ]
1.16 | [solubility ]
DMF: 5 mg/ml; DMSO: 3 mg/ml; Ethanol: 5 mg/ml; Ethanol:PBS(pH 7.2) (1:5): 0.16 mg/ml; Methanol: 1 mg/ml | [form ]
A crystalline solid | [pka]
7.07±0.10(Predicted) |
| Hazard Information | Back Directory | [Description]
A-796260 is a synthetic cannabinoid (CB) that shows high selectivity for the CB2 receptor (Ki = 0.77 nM) over the CB1 receptor (Ki = 2,100 nM). It also shows efficacy in vivo in models of inflammatory, post-operative, neuropathic, and osteoarthritic pain, activities which are selectively blocked by CB2 receptor-selective antagonists. This product is intended for research and forensic uses. | [Uses]
A-796,260 is a synthetic cannabinoid that shows high selectivity towards CB2 receptor over the CB1 receptor. A-796,260 showed high efficacy in models of inflammatory, post-operative, neuropathic and OA pain in vivo. |
|